Precision Medicine Group is a global team of 3,500 experts providing research and commercialization services to pharmaceutical and life-sciences companies. Founded in 2012, the firm operates through two main divisions: Precision for Medicine, which offers biomarker-driven research and development services, and Precision AQ, which provides commercialization support from product launch through maturity.
The company's technical capabilities span advanced lab sciences, translational informatics, regulatory affairs, payer insights, data analytics, and manufacturing advancement. This breadth enables the firm to support clients across the drug development lifecycle, from early-stage research through market commercialization. The emphasis on biomarker-driven approaches and data analytics reflects a focus on precision-based strategies in product development and market positioning.
As a fully integrated operation, Precision Medicine Group brings together specialists from diverse disciplines to work collaboratively on client challenges. The scale and scope of the firm's expertise positions it to handle complex, multi-faceted projects requiring coordination across scientific, regulatory, commercial, and manufacturing domains.